HIMS - 24/7 Market News Lunchtime Pitch

2024-05-30 13:17:18 ET

DENVER, Colo., May 30, 2024 ( 247marketnews.com )- Brera Holdings PLC (Nasdaq:BREA), Sharps Technology, Inc. (NASDAQ:STSS), OneMedNet Corporation (Nasdaq:ONMD), Momentus Inc. (NASDAQ:MNTS), Faraday Future Intelligent Electric (Nasdaq: FFIE), Hims & Hers Health, Inc. (Nasdaq:HIMS), and C3.ai, Inc. (NYSE:AI)

Brera Holdings PLC (Nasdaq: BREA ) is partnering with THADDBOII, a social influencer with over 3 billion views, who will produce a 24-episode TikTok and YouTube series dedicated to showcasing the exciting journey of Brera Holdings’ global expansion, slated to premiere on June 20, to increase engagement, drive traffic, and offer unparalleled visibility and branding opportunities for Brera Holdings leading up to one of the world’s most anticipated sporting events.

“We are thrilled to partner with THADDBOII, a true visionary whose work has inspired countless young athletes around the globe. It’s an honor to have Brera Holdings featured in a brand new sports series, with a creator that truly understands the value of social equality,” commented Pierre Galoppi, CEO of Brera Holdings. “With the 2026 World Cup on the horizon, and soccer’s growing popularity in North America, this collaboration is set to introduce Brera to a vast new audience, showcasing our unique journey through THADDBOII’s engaging storytelling and creative flair.”

Sharps Technology, Inc. (NASDAQ: STSS ) signed a $200 million syringe Sales Agreement, over 5 years, with Nephron Pharmaceuticals in conjunction with Sharps Technology’s Asset Purchase Agreement to acquire the InjectEZ specialty syringe manufacturing assets in West Columbia, South Carolina, which will be the only fully dedicated, specialized COC (cyclic olefin copolymer) prefillable syringe manufacturing plant in North America.

Robert Hayes, Sharps Technology CEO, stated, “Sharps will now have manufacturing operations in Europe and the United States, and this deal will generate significant short and long-term revenue for the Company. This transaction enables Sharps to enter the highly profitable copolymer prefillable syringe market segment, which is showing the greatest growth rate in the syringe marketplace. With the associated $200 million Sales Agreement in place for copolymer prefillable syringes, we will substantially accelerate Sharps’ revenue growth allowing the Company to create a new level of revenue and performance.

“Together, these landmark transactions will undeniably position the Company for future growth, providing meaningful benefits to both patients and shareholders.”

OneMedNet Corporation (Nasdaq: ONMD ) entered into a non-exclusive three-year Master Services Agreement with an unnamed American medical technology company that affects more than 150 million patients worldwide annually, which will utilize OneMedNet’s iRWD platform.

“As medical device companies increasingly look to leverage the use of existing RWD, particularly medical imaging data, across many stages of development, from ideation up to and including post-market surveillance, there is growing industry awareness and adoption of our highly differentiated iRWD™ platform,” stated OneMedNet’s President and CEO, Aaron Green. “By providing timely access to de-identified and hard-to-curate current clinical information to this global medical technology industry leader, our aim is to not only provide it with comprehensive, accurate, and much needed patient information, but also help improve its competitive positioning by enabling it better informed decision-making.”

Momentus Inc. (NASDAQ: MNTS ) was awarded a Defense Advanced Research Projects Agency (DARPA) contract to support the Novel Orbital and Moon Manufacturing, Materials, and Mass-efficient Design (NOM4D) program, which is a design and in-space demonstration of technologies that will enable the construction of large-scale structures in space.

“We’re delighted by the opportunity to partner with DARPA to work at the forefront of the future in-space infrastructure economy,” commented John Rood, Momentus Chief Executive Officer. “Vigoride’s flexibility, payload capacity, and power make it well-suited to support the demonstration of NOM4D technologies that overcome current volume, load, and vibration constraints currently limiting the type and scale of in- space structures.”

Hims & Hers Health, Inc. (Nasdaq: HIMS ) set a new 52-week high today. It recently announced the addition of GLP-1 injections to its comprehensive weight loss portfolio, giving customers an affordable way to consistently access safe, high-quality weight loss treatment.

“The core of our business is to offer a truly personalized experience that customers can trust and rely on,” commented Andrew Dudum, CEO and co-founder of Hims & Hers. “We’ve leveraged our size and scale to secure access to one of the highest-quality supplies of compounded GLP-1 injections available today. We’re passing that access and value along to our customers, who deserve the highest standard of clinical safety and efficacy to meet their goals, and we’re doing it in a safe, affordable way that others can’t deliver.”

C3.ai, Inc. (NYSE: AI ) reported its fiscal fourth quarter and full fiscal year ended April 30, 2024 financial results.

“We finished a strong quarter and closed out a huge year for C3 AI. This was our fifth consecutive quarter of accelerating revenue growth. Our fourth quarter revenue grew by 20% year-over-year to $86.6 million, exceeding the top end of our guidance. Our full year revenue grew by 16% to $310.6 million, also exceeding the top end of our guidance,” commented Thomas M. Siebel, C3 AI’s CEO and Chairman. “Demand for Enterprise AI is intensifying, and our first to market advantage in Enterprise AI positions us well to capitalize on it. Our Enterprise AI applications have been adopted across 19 industries, underscoring increasing market diversity. Our federal revenue grew by more than 100% for the year. The interest we are seeing in our generative AI applications is staggering.”

The post 24/7 Market News Lunchtime Pitch appeared first on 24/7 MarketNews .

For further details see: